Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
OBEcure Ltd. |
---|---|
Information provided by: | OBEcure Ltd. |
ClinicalTrials.gov Identifier: | NCT00409305 |
The purpose of this study is to examine the effect that betahistine has on body weight in obese subjects.
Condition | Intervention | Phase |
---|---|---|
Obesity |
Drug: Betahistine Behavioral: Dietary counseling |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Subjects |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Alabama | |
Cahaba Research, Inc. | |
Birmingham, Alabama, United States, 35242 | |
United States, California | |
Scripps Clinic, Nutrition Metabolic Research | |
San Diego, California, United States, 92130 | |
Diablo Clinical Research, Inc. | |
Walnut Creek, California, United States, 94598 | |
United States, Florida | |
Miami Research Associates, Inc., Nutrition Division | |
Miami, Florida, United States, 33143 | |
United States, Georgia | |
CSRA Partners in Health, Inc. | |
Augusta, Georgia, United States, 30909 | |
United States, Illinois | |
Radiant Research, Inc. | |
Chicago, Illinois, United States, 60610 | |
NCCR | |
Chicago, Illinois, United States, 60611 | |
United States, Indiana | |
American Health Network | |
Indianapolis, Indiana, United States, 46254 | |
Midwest Institute for Clinical Research | |
Indianapolis, Indiana, United States, 46260 | |
United States, Kansas | |
Radiant Research, Inc. | |
Overland Park, Kansas, United States, 66215 | |
United States, Kentucky | |
L-MARC Research Center | |
Louisville, Kentucky, United States, 40213 | |
United States, Louisiana | |
Pennington Biomedical Research Center | |
Baton Rouge, Louisiana, United States, 70808 | |
United States, Minnesota | |
Radiant Research, Inc. | |
Edina, Minnesota, United States, 55435 | |
United States, Missouri | |
Diabetes & Endocrinology Specialists | |
Chesterfield, Missouri, United States, 63017 | |
United States, New York | |
Comprehensive Weight Control Program | |
New York, New York, United States, 10021 | |
Rochester Clinical Research, Inc. | |
Rochester, New York, United States, 14609 | |
United States, Ohio | |
Lindner Clinical Trial Center | |
Cincinnati, Ohio, United States, 45219 | |
United States, Oregon | |
Covance CRU, Inc. | |
Portland, Oregon, United States, 97239 | |
United States, Texas | |
Diabetes & Glandular Disease Research Associates, Inc. | |
San Antonio, Texas, United States, 78229 |
Principal Investigator: | Andrew Ahmann, MD | Covance CRU, Inc |
Principal Investigator: | Louis Aronne, MD | Comprehensive Weight Control Program |
Principal Investigator: | Harold Bays, MD | L-Marc Research Center |
Principal Investigator: | Norman Fishman, MD | Diabetes & Endocrinology Specialists |
Principal Investigator: | Ken Fujioka, MD | Scripps Clinic, Nutrition Metabolic Research |
Study Director: | Jeffrey Geohas, MD | Radiant Research, Inc |
Principal Investigator: | Frank Greenway, MD | Pennington Biodmedical Research Center |
Principal Investigator: | Dean Kereiakes, MD | Lindner Clinical Trial Center |
Principal Investigator: | Diane Krieger, MD | Miami Research Associates, Nutrition Division |
Principal Investigator: | Robert Kushner, MD | NCCR |
Principal Investigator: | Thomas Moretto, MD | American Health Network |
Principal Investigator: | Monica Pierson, MD | Radiant Research |
Principal Investigator: | Sherwyn Schwartz, MD | Diabetes & Glandular Disease Research Associates |
Principal Investigator: | Diane Smith, MD | CSRA Partners in Health |
Principal Investigator: | Philip Toth, MD | Midwest Institute for Clinical Research |
Principal Investigator: | Mervyn Weerasinghe, MD | Rochester Clinical Research |
Principal Investigator: | Richard Weinstein, MD | Diablo Clinical Research |
Principal Investigator: | Lisa Wright, MD | Cahaba Research, Inc |
Principal Investigator: | James Zavoral, MD | Radiant Research, Inc. |
Study Director: | Nir Barak, MD | OBEcure Ltd. |
Study Chair: | Yaffa Beck, PhD | OBEcure Ltd. |
Study Chair: | Ami Eyal, MD | OBEcure Ltd. |
Study ID Numbers: | BET201 |
Study First Received: | December 6, 2006 |
Last Updated: | August 3, 2007 |
ClinicalTrials.gov Identifier: | NCT00409305 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Body Weight Signs and Symptoms Obesity Vasodilator Agents Neurotransmitter Agents Histamine phosphate |
Nutrition Disorders Betahistine Overweight Overnutrition Cardiovascular Agents Histamine |
Obesity Vasodilator Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Histamine Agents Overweight Betahistine |
Cardiovascular Agents Pharmacologic Actions Body Weight Signs and Symptoms Histamine Agonists Therapeutic Uses Nutrition Disorders Overnutrition |